Sign in

CIK 0001501989 · Accelerated filer

CytomX Therapeutics, Inc.

Sign in to watch
Ticker
CTMX
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
273521219
Phone
650.515.3185
Business address
151 OYSTER POINT BLVD., SUITE 400, SOUTH SAN FRANCISCO, CA, 94080
  1. 4 Derivatives Options or other derivatives
  2. 4 Derivatives Options or other derivatives
  3. 4 Derivatives Options or other derivatives
  4. 4 Derivatives Options or other derivatives
  5. 4 Derivatives Options or other derivatives
  6. 4 Derivatives Options or other derivatives
  7. 4 Open-market sale Chief Financial Officer sold 1,624 shares at $3.05 ($4,953)
  8. 8-K Event Material agreement
  9. SCHEDULE 13G/A Stake Statement of Beneficial Ownership
  10. SCHEDULE 13G/A Stake Statement of Beneficial Ownership
  11. SCHEDULE 13G/A Stake Statement of Beneficial Ownership
  12. SCHEDULE 13G/A Stake Statement of Beneficial Ownership
  13. SCHEDULE 13G/A Stake Statement of Beneficial Ownership
  14. 8-K Event Results of operations
  15. 10-Q Report Quarterly Report
  16. DEFA14A Proxy Proxy Materials
  17. DEF 14A Proxy Proxy Statement
  18. PRE 14A Proxy Proxy Statement (Preliminary)
  19. SCHEDULE 13G Stake Statement of Beneficial Ownership
  20. SCHEDULE 13G/A Stake Statement of Beneficial Ownership

Page 2 of 41 · 801 filings